Press Releases

Press Releases

Morphic to Present at the Jefferies 2019 London Healthcare Conference

November 18, 2019
WALTHAM, Mass. , Nov. 18, 2019 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that Praveen Tipirneni , M.D., president and chief executive

Morphic Announces Pricing of Upsized Initial Public Offering

June 26, 2019
WALTHAM, Mass. --(BUSINESS WIRE)--Jun. 26, 2019-- Morphic Holding, Inc. (“ Morphic ”), a biopharmaceutical company discovering and developing oral small-molecule integrin therapeutics, today announced the pricing of its upsized initial public offering of 6,000,000 shares of its common stock at a